MORTIMER IAN (PRESIDENT & CFO) purchased 150.6% of their position (30K shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $1.12M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/1/2026ACC: 0001193125-26-409999
Officer· PRESIDENT & CFO
Since Sep 2019
+30K
Net shares
Net buyer
$1.12M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
30K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+30K
Price / share
$37.38
Trade value
$1.12M
% of position
150.6%
9/30/2026
19.92K→49.92K
Total
Net shares
+30K
Net value
$1.12M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/30/2026 | P · Purchase | +30K | $37.38 | $1.12M | 150.6% | 19.92K | 49.92K |
| Total | +30K | $1.12M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Shares
IndirectShares owned14.30K
Total
14.30K indirect14.30K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 14.30K | Indirect |
| Total | 14.30K | 14.30K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported